RNF11 and neoplasm: TMA technology allowed for a rapid and simultaneous analysis of RNF11 protein expression in 125 primary tumours microarrayed in duplicate by immunohistochemical staining using anti-RNF11 antibody (Kononen et al, 1998; Landberg et al, 2001).